Compare BX & MO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BX | MO |
|---|---|---|
| Founded | 1985 | 1822 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.4B | 98.6B |
| IPO Year | 2007 | 1994 |
| Metric | BX | MO |
|---|---|---|
| Price | $109.90 | $64.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $169.50 | $63.63 |
| AVG Volume (30 Days) | ★ 9.0M | 7.2M |
| Earning Date | 04-16-2026 | 04-28-2026 |
| Dividend Yield | 4.18% | ★ 6.52% |
| EPS Growth | ★ 6.91 | N/A |
| EPS | 3.87 | ★ 4.12 |
| Revenue | $14,450,265,000.00 | ★ $23,279,000,000.00 |
| Revenue This Year | $14.56 | $3.48 |
| Revenue Next Year | $21.82 | $0.33 |
| P/E Ratio | $29.32 | ★ $15.80 |
| Revenue Growth | ★ 9.22 | N/A |
| 52 Week Low | $101.73 | $53.41 |
| 52 Week High | $190.09 | $70.51 |
| Indicator | BX | MO |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 39.63 |
| Support Level | $103.41 | $63.18 |
| Resistance Level | $165.14 | $67.12 |
| Average True Range (ATR) | 4.27 | 1.18 |
| MACD | 1.37 | -0.58 |
| Stochastic Oscillator | 54.35 | 1.87 |
Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.